In a world obsessed with consumer apps and viral growth, SciencePharma operates in the shadows of the pharmaceutical industry—where a single regulatory misstep can cost millions and delay life-saving treatments. They're not building the next unicorn; they're ensuring the entire industry doesn't collapse under regulatory weight.

""More than consulting" isn't just a tagline—it's a warning to competitors who think regulatory affairs is a commodity business."

The tech stack reveals a pragmatic approach: jQuery, Bootstrap, and HubSpot suggest they prioritize functionality over flash. This is a firm that understands its audience—busy regulatory affairs directors who need clear information fast, not flashy animations. The absence of Trustpilot reviews isn't a red flag; in B2B pharma consulting, reputation is built through relationships, not public ratings.

• Deep specialization in regulatory affairs (CTD templates, GMP audits, pharmacovigilance)
• Mid-sized scale with enterprise capabilities (128 employees, $25.7M revenue)
• High-intent traffic strategy targeting specific regulatory pain points
• LinkedIn and Twitter presence focused on industry thought leadership, not consumer engagement